Opioid Abuse

Education, Depression, Pain Associated With Opioid Misuse

Education, Depression, Pain Associated With Opioid Misuse

In adults age 50 or older, higher education, illicit drug use, depression, and pain interference with normal work are significantly associated with opioid misuse.

Intentional Poisoning as a Method for Obtaining Opioid Medications

Intentional Poisoning as a Method for Obtaining Opioid Medications

By

According to the authors, this report represents the first case of recurrent fallacious lactatemia secondary to EG poisoning in the setting of drug-seeking behavior.

Long-Term Opioid Use Increases Asthma, Allergic Rhinitis Prevalence

Long-Term Opioid Use Increases Asthma, Allergic Rhinitis Prevalence

By

In addition to their analgesic effects, opioid binding to opioid receptors leads to the release of histamine from mast cells, including those implicated in asthma and allergic rhinitis.

Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose

Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose

By

Medical marijuana laws that include a "liberal" allowance of the drug to dispensaries may contribute to reducing opioid overdose-related deaths in Medicare Part-D and Medicaid beneficiaries.

Guidelines on the Perioperative Pain Management of Patients on Buprenorphine Therapy

Guidelines on the Perioperative Pain Management of Patients on Buprenorphine Therapy

By

Clinical best practice recommendations for the use of buprenorphine in the perioperative management of patients undergoing interventional pain procedures and other surgeries were recently published.

Comparing the Efficacy of Extended-Release Naltrexone and Buprenorphine-Naloxone on Opioid Relapse

Comparing the Efficacy of Extended-Release Naltrexone and Buprenorphine-Naloxone on Opioid Relapse

By

Extended-release naltrexone and sublingual buprenorphine-naloxone were equally effective for preventing opioid abuse relapse.

FDA Tentatively Approves Arymo ER Label Update for Abuse-Deterrent Claims

FDA Tentatively Approves Arymo ER Label Update for Abuse-Deterrent Claims

By

The FDA has tentatively approved an update to the Arymo ER extended-release tablets labeling to include data from an intranasal abuse-deterrent claim.

Investigational Oxycodone Vaccine Shows Potential for Oxycodone Abuse, Overdose

Investigational Oxycodone Vaccine Shows Potential for Oxycodone Abuse, Overdose

By

An investigational vaccine may represent an effective treatment strategy for oxycodone abuse and may help reduce oxycodone overdose severity.

SAMHSA: Opioid Abuse Rates Up Among Older Adults

SAMHSA: Opioid Abuse Rates Up Among Older Adults

While opioid abuse among young adults had decreased, abuse rates in adults 50 years and older has doubled, from 1.1 to 2.0%.

FDA to Remove Pain Drug from the Market

FDA to Remove Pain Drug from the Market

By

The FDA has requested the removal of reformulated Opana ER (oxymorphone HCl; Endo) from the market.

CDC Guideline on Prescribing Opioids: Some Major Concerns

CDC Guideline on Prescribing Opioids: Some Major Concerns

By

Dr Fudin discusses concerns he has regarding the CDC guideline for prescribing opioids for chronic pain.

Naltrexone vs Buprenorphine to Treat Opioid Dependence

Naltrexone vs Buprenorphine to Treat Opioid Dependence

By

An 8-day detoxification process using low-dose oral naltrexone showed superior efficacy to the standard 15-day approach that uses an agonist taper leading to induction with extended-release naltrexone

Number of Women Using Opioids During Pregnancy Up

Number of Women Using Opioids During Pregnancy Up

Over a decade, there was a nearly 5-fold increase in the number of infants born each year to American women who used opioids during the pregnancy.

Sudden-Onset Amnesia Seen With Opioid Abuse

Sudden-Onset Amnesia Seen With Opioid Abuse

Short-term memory loss may be yet another price of America's opioid addiction epidemic.

3 Noteworthy Initiatives To Address the Opioid Epidemic

3 Noteworthy Initiatives To Address the Opioid Epidemic

By

The initiatives include guidelines and recommendations for CRNAs, physicians, and policymakers.

Managing Chronic Pain During the Opioid Overuse Epidemic

Managing Chronic Pain During the Opioid Overuse Epidemic

By

A high level of comorbidity exists between substance use disorders and chronic pain.

Preventing Opioid Dependency With Low Initial Dose, No Refills

Preventing Opioid Dependency With Low Initial Dose, No Refills

The risk of long-term opioid use can be reduced by prescribing a short-acting painkiller with no refills.

Low Risk of Post-Operative Opioid Abuse for Elderly Patients

Low Risk of Post-Operative Opioid Abuse for Elderly Patients

Vast majority of patients use the meds short term to ease their pain

A Pain Clinician's Perspective on the Comprehensive Addiction and Recovery Act

A Pain Clinician's Perspective on the Comprehensive Addiction and Recovery Act

By

There is a lot of opportunity to improve on what can be offered to patients.

A Successful Multipronged Approach to Reduce Opioid Abuse

A Successful Multipronged Approach to Reduce Opioid Abuse

By

Implementation of the Narcotic Safety Initiative has been successful in California one year after its launching.

Opioid Prescriptions Drop for First Time in Two Decades

Opioid Prescriptions Drop for First Time in Two Decades

Do government efforts to curb opioid use play a role in the observed reduction of drug use?

Endomorphin Analog Analgesics: An Alternative to Opioids?

Endomorphin Analog Analgesics: An Alternative to Opioids?

By

These compounds, through selective µ-opioid receptor activation, could provide a safer alternative to opioids in treating three major types of pain.

American Society of Anesthesiologists Introduces New Committee to Address Opioid Abuse

American Society of Anesthesiologists Introduces New Committee to Address Opioid Abuse

By

The ASA has announced the creation of its Ad Hoc Committee on Prescription Opioid Abuse to help address the country's growing epidemic.

FDA Issues Draft Guidance for Development of Abuse-Deterrent Opioids

FDA Issues Draft Guidance for Development of Abuse-Deterrent Opioids

By

The FDA has announced the steps it plans to take in order to expand the use of abuse-deterrent opioids.

Military Medical School Addresses Opioid Epidemic by Incorporating Joint Pain Education Into Curriculum

Military Medical School Addresses Opioid Epidemic by Incorporating Joint Pain Education Into Curriculum

By

The F. Edward Hebert School of Medicine at the USU this week announced the addition of a new pain management program that incorporates joint pain education into its curriculum

White House Continues Efforts to Curb Opioid, Heroin Abuse

White House Continues Efforts to Curb Opioid, Heroin Abuse

By

President Barack Obama will announce new public and private initiatives directed at curbing opioid abuse across the country.

Sign Up for Free e-Newsletters